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Chlamydia trachomatis is the leading cause of bacterial sexually transmitted infections
(STIs) and preventable blindness. Untreated, asymptomatic infection as well as frequent
re-infection are common and may drive pelvic inflammatory disease, ectopic pregnancy,
and infertility. In vivo models of chlamydial infection continue to be instrumental in
progress toward a vaccine and further elucidating the pathogenesis of this intracellular
bacterium, however significant gaps in our understanding remain. Chlamydial host cell
exit occurs via two mechanisms, lysis and extrusion, although the latter has yet to
be reported in vivo and its biological role is unclear. The objective of this study was
to investigate whether chlamydial extrusions are shed in vivo following infection with
multiple strains of Chlamydia. We utilized an established C3H/HeJ murine cervicovaginal
infection model with C. trachomatis serovars D and L2 and the Chlamydia muridarum
strain MoPn to monitor the (i) time course of infection and mode of host cell exit, (ii)
mucosal and systemic immune response to infection, and (iii) gross and histopathology
following clearance of active infection. The key finding herein is the first identification of
chlamydial extrusions shed from host cells in an in vivo model. Extrusions, a recently
appreciated mode of host cell exit and potential means of dissemination, had been
previously observed solely in vitro. The results of this study demonstrate that chlamydial
extrusions exist in vivo and thus warrant further investigation to determine their role in
chlamydial pathogenesis.
Keywords: chlamydia, extrusion, lymphogranuloma venereum, sexually transmitted infection, urogenital infection,
MoPn, Serovar D
INTRODUCTION
Chlamydia trachomatis is a pathogen of global significance, causing ocular trachoma, and
urogenital infections. The species is comprised of at least 15 different serovars that are
categorized into two separate biovars, (i) trachoma, which causes ocular disease (serovars A to
C) and genital mucosa disease (serovars D to K), and (ii) lymphogranuloma venereum (LGV;
serovars L1 to L3; Schachter, 1999). In the United States urogenital C. trachomatis infections
are the most common bacterial sexually transmitted infections (STIs) reported by the CDC
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(Centers for Disease Prevention, 2011). Despite treatment,
ongoing complications may arise after infection including
pelvic inflammatory disease (PID), endometriosis, tubal scarring,
ectopic pregnancy, and potentially cervical cancer (Smith et al.,
2001; Brunham and Rey-Ladino, 2005).
Chlamydiae are a group of obligate intracellular bacteria that
possess a unique biphasic life cycle consisting of two alternating
forms: infectious, non-replicative, extracellular elementary
bodies (EBs) and non-infectious, metabolically active, replicative
reticulate bodies (RBs; Moulder, 1991). Upon binding of the
EB to the host cell, the EB is endocytosed and contained within
a membrane bound vacuole, termed an inclusion, and avoids
lysosomal fusion (Fields and Hackstadt, 2002). From within
the protection of the inclusion, EBs quickly differentiate into
metabolically active RBs, which replicate via polarized budding
process (Abdelrahman et al., 2016). Upon the host cell swelling in
response to the growing numbers of Chlamydia, the Chlamydia
exit the cell by one of two mechanisms: lysis or extrusion
(Todd and Caldwell, 1985; Scidmore et al., 1996; Hybiske and
Stephens, 2007, 2008; Lutter et al., 2013) for subsequent rounds
of infection. Extrusion studies to date have been performed in
vitro utilizing many cell types and chlamydial strains (Todd and
Caldwell, 1985; Hybiske and Stephens, 2007, 2008; Chin et al.,
2012; Lutter et al., 2013; Zuck et al., 2016a,b); however, the role
of extrusions in chlamydial pathogenesis in vivo has not yet been
described.
To investigate the mechanisms and outcomes of C.
trachomatis infections, a female mouse urogenital infection
model has been extensively studied with Chlamydia muridarum
strains (Barron et al., 1981; Swenson et al., 1983; Ramsey et al.,
2009) and human C. trachomatis urogenital isolates (Tuffrey
et al., 1986). Several attributes of this model closely resemble
acute genital tract infections in human females. Typically mice
resolve chlamydial infections within 4 weeks and develop
subsequent immunity (Morrison and Caldwell, 2002), which can
differ between C. trachomatis strains and C. muridarum strains
(Lyons et al., 2005; Morrison et al., 2011; De Clercq et al., 2013).
To date, much knowledge has been gained regarding
infectivity, pathogenicity, fertility, and potential vaccine
candidates for C. muridarum (MoPn) and C. trachomatis
infections in the murine model (Perry and Hughes, 1999; Pal
et al., 2001; Morrison and Caldwell, 2002; Kari et al., 2011;
Morrison et al., 2011; Schautteet et al., 2011; Yu et al., 2012;
De Clercq et al., 2013). In the literature there is a wide range
of techniques, protocols, end point assays, chlamydial strains
used for infection, and different mouse strains potentially
confounding the interpretation of data across different studies.
Thorough comparative studies across chlamydial strains have
recently been published to address these issues, such as the
one published by Morrison et al. (2011). However, there are no
reports to date that have investigated the presence of chlamydial
extrusions shed in vivo. Therefore, the objective of this study
was to monitor the course of murine chlamydial infection while
investigating the mode by which organisms are shed in vivo
following infection across multiple strains of Chlamydia. Here,
we present a comparison of the urogenital serovar D-LC, the
LGV serovar L2 of C. trachomatis, and MoPn (Nigg) of C.
muridarum infection in C3H/HeJ mice, a currently accepted
mouse strain for optimal modeling of a robust cervicovaginal
infection (Bernstein-Hanley et al., 2006). Overall, the findings
are consistent with the expected time course of chlamydial
infections, immune response generated, and resultant pathology
while providing novel data on the mode of host-cell chlamydial
shedding from the murine cervicovaginal tract. We document
the first account of chlamydial extrusions in an in vivo model.
This novel finding warrants further research in chlamydial
pathogenesis.
METHODS
Chlamydial Strains and Cell Culture
C. trachomatis serovars D-Late Clearance (D-LC; Sturdevant
et al., 2010), L2 (LGV 434), and C. muridarum mouse
pneumonitis (MoPn, Nigg) were propagated in HeLa 229 cells
and purified by Renografin density gradient centrifugation as
previously described (Caldwell et al., 1981). HeLa cells were
grown in RPMI 1640 + 10% fetal bovine serum (FBS) at
37◦C with 5% CO2 and 1 ug/mL cycloheximide added as
needed.
Cervicovaginal Infection of Mice
Six week old female inbred C3H/HeJ mice (innate immune-
deficient) were purchased from Jackson Laboratories (Bar
Harbor, Maine). All animal work was performed according to
The Animal Care and Use Guidelines and approved by the
Institution of Animal Care and Use Committee at Oklahoma
State University. At 10 and 7 days prior to infection, all mice were
subcutaneously injected with 2.5mg of medroxyprogesterone
acetate (Upjohn, Kalamazoo, MI) to synchronize estrus. Mice
were divided into four groups (n = 15 per group): sham, C.
trachomatis serovar D-LC, C. trachomatis serovar L2, and C.
muridarum (MoPn). Mice were infected intravaginally with 1 ×
106 EBs in 5 µL sucrose-phosphate-glutamate (SPG). Control
mice were sham infected via intravaginal administration of 5
µL of SPG alone. Of the 15 mice within each group, 10 mice
were dedicated to enumeration of IFU while the remaining
five mice per group were strictly dedicated to the recovery of
extrusions shed from the cervicovaginal tract. An additional
experiment was conducted using mice (n = 10) treated with
medroxyprogesterone acetate and infected with L2, as described
above, to further confirm the presence of extrusions shed
in vivo.
Quantification of Recoverable IFUs from
the Cervicovaginal Tract
At days 3, 7, 14, 21, 28, 35, and 59 days post infection,
cervicovaginal tracts were swabbed via 8 rotations to the right
and 8 rotations to the left (Puritan Diagnostics, HydraFlock
6′′ 15 cm swabs; Guilford, ME) and each swab was added to
tubes containing 600 µL SPG and two glass beads on ice, as
adopted from previously described studies (Shaw et al., 2001;
Cheng et al., 2008; Chen et al., 2014). Swab samples were
vortexed vigorously to liberate EBs from the swab followed
by serial dilution and inoculation of confluent HeLa cell
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monolayers in 24 well plates (CellTreat Scientific, MA). Plates
were centrifuged at 700 × g for 1 h to promote EB entry.
Inoculated HeLa monolayers were incubated in RPMI 1640
+ 10% FBS for 24–34 h at 37◦C with 5% CO2. Plates were
fixed with methanol and stained with anti-MOMP (MOMP
antibody recognizes both C. trachomatis and C. muridarum,
courtesy of Dr. Harlan Caldwell) followed by anti-mouse DyLight
488 (Jackson Immunoresearch, Westgrove PA). Twenty fields
of view were counted using a Leica MI6000B fluorescent
microscope. Total recoverable IFUs/mouse were calculated for
each sample.
Microscopy of Extrusions Shed from the
Cervicovaginal Tract
Collection and Preparation of Extrusions for Live Cell
Imaging
At days 10, 17, and 24 post-infection the cervicovaginal
tracts were swabbed as described above then placed into
100 µL of RPMI 1640 + 10% FBS on ice. Swab samples
were gently swirled to release extrusions; samples were not
vortexed due to the fragile nature of extrusions. Samples were
centrifuged at 75 × g and supernatant removed. The pellet
was resuspended in 100 µL RMPI+10% FBS and stained with
Hoechst NucBlue R© Live ReadyProbes R© (1:200) Reagent and
FM 4-64 (Thermo Fisher Scientific; 5 µg/mL). Wet mounts
were prepared and visualized under oil using an Olympus IX81
Spinning Disc Confocal microscope; differential interference
contrast (DIC) and live cell fluorescent images of extrusions were
captured.
Collection and Preparation of Extrusions for Fixed
Cell Imaging
To confirm the presence of chlamydial EBs housed inside
extrusions an additional murine study was performed using L2-
infected mice, as described above. At 17 and 20 days post-
infection cervicovaginal tracts were swabbed for extrusions (n =
5), as described above, or lavage (n = 5) performed by gently
washing the vaginal tract with 60 µL RPMI 1640 + 10% FBS
twice to produce a 120 µL lavage sample per mouse for analysis.
Pooled swab and pooled lavage samples were centrifuged at
75 × g to enrich extrusions. The pellets were resupended in
200 µL RPMI 1640 + 10% FBS and stained with aldehyde
fixable analog, FM 4-64FX (Thermo Fisher Scientific; 5 µg/mL),
for 10 min. Samples were then centrifuged at 75 × g and
fixed with 4% paraformaldehyde. Chlamydial EBs were labeled
with anti-L2 and anti-rabbit DyLight 488 secondary antibodies
(Jackson Immuno Research); nuclei were stained with DAPI
(4′,6′-diamidino-2-phenylindole; Thermo Fisher Scientific; 0.5
µg/ml). Next, samples were mixed with ProLong Diamond
Antifade Mountant (Thermo Fisher Scientific), mounted onto
glass slides and viewed using a Leica DMI6000B microscope.
Enzyme-Linked Immunosorbent Assay
(ELISA)
To measure the murine mucosal and systemic immune response
to infection, vaginal washes and sera were collected 31 and
35 days post infection, respectively, for ELISA. Vaginal washes
were obtained by gently washing the vaginal vault with 60 µL
0.5% BSA-PBS twice and stored at −20◦C until the ELISA
was performed. Briefly, 96-well polystyrene plates (Immulon
2HB; Thermo, Milford, MA) were coated with 1 µg of
formalin fixed EBs (serovar D-LC, serovar L2, and MoPn)
per well in 100 µL TBS (50 mM Tris buffer pH 7.5, 0.15
M NaCl) overnight at 4◦C. Following adsorption of fixed
EBs, wells were washed to remove unbound EBs then blocked
with 200 µL 2% BSA in 0.012 M Tris pH 7.4, 0.14 M
NaCl, 3.0 mM KCl, 0.05% Tween 20 for 90 min at 37◦C.
Plates were washed and serial dilutions of vaginal washes and
sera were added to appropriately matched wells (e.g., vaginal
washes from serovar D-LC infected mice added to plates
with serovar D-LC fixed EBs). Plates were incubated for 90
min at 37◦C. Chlamydial-specific antibodies were detected in
vaginal wash and sera samples using alkaline phosphatase-
conjugated anti-mouse IgA and IgG isotype-specific antibodies
(Southern Biotech Associates, Birmingham, AL), respectively.
P-nitrophenyl phosphate (PNPP) was used as a substrate and
resulting absorbance was read at 405 nm (BioTek Synergy,
Winooski, VT). Vaginal washes and sera from sham mice were
used as negative controls. Antibody titers were considered
positive at the highest sample dilution that displayed an
absorbance that was ≥3X the absorbance of the concentrated
sham samples.
Histopathology
Mouse uteri were excised and immersion fixed in 10% buffered
neutral formalin. Following fixation, they were processed entire
and embedded en bloc into paraffin followed by sections cut
at 4 µm and staining with hematoxylin and eosin (H&E).
Sections were examined and scored via light microscopy
by an American College of Veterinary Pathologists (ACVP)
certified veterinary pathologist with the following numerical
designations: 0, normal; 1, minimal change; 2, mild change;
3, moderate change; 4, severe change. Scored parameters
(mean ± SD) included an overall impression, periglandular
mucinous change, hydrosalpinx, uterine luminal, and stratum
compactum inflammation. Additionally, endometrial luminal
epithelial height was subjected to morphometric analyses
focused on epithelial height as determined by calibrated
measurements via Olympus CellSens software coupled to an
Olympus DP70 microscope camera. Each reproductive tract
was evaluated regionally and morphometrically at six locations
(proximal, mid-, and distal locations of the two uterine horns)
determined to be uniform and free of tissue bends and
curves; epithelial height (mean µm ± SD) was measured
from the basement membrane to the most apical cytoplasmic
membrane.
Statistics
One way ANOVA (Prism 3.0) was used to analyze the recoverable
IFU and immunoglobulin data sets of sham vs. each of
the three infected groups (D-LC, L2, MoPn) followed by
Tukey post hoc analysis (significance at p < 0.05). One way
ANOVA of morphometric measurements of epithelial height
and post hoc Student’s two-way t-test with equal variances
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were performed between sham infected (n = 3) and each
(n = 3) of the infected groups (D-LC, L2, MoPn) with
significance assignedmost conservatively at p< 0.016 (0.05/three
tests).
RESULTS
Recoverable IFUs during C. trachomatis
and C. muridarum Infection
Medroxyprogesterone acetate treated female 6 week old C3H/HeJ
mice were cervicovaginally infected with 1 × 106 IFUs of either
C. trachomatis D-LC, C. trachomatis L2, or C. muridarum.
Infectious burden and duration was monitored via swabbing the
vaginal vault (n = 10) and culturing in HeLa cells at weekly
intervals through day 35 post infection (and again on day 59 to
confirm that clearance of infection was complete). Quantification
of recoverable IFUs are shown in Figure 1. Infection by all
three strains was self-limiting with peaks of infection occurring
on day 14 after which infectious burden decreased steadily. C.
trachomatis L2 resulted in infection with the greatest recoverable
IFUs (p < 0.001 L2 vs. D-LC; p < 0.001 L2 vs. MoPn) while
C. muridarum and C. trachomatis serovar D-LC presented with
similar infection burdens throughout the course of infection. At
day 59 post infection mice displayed no evidence of infection
(data not shown); mice were euthanized by cervical dislocation
FIGURE 1 | Comparison of recoverable infectious forming units (IFUs)
obtained from C3H/HeJ mice between C. trachomatis (serovars D-LC,
L2) and C. muridarum (MoPn) infection. Mice were intravaginally infected
with 1X 106 EBs of corresponding Chlamydial strain. Recoverable IFUs were
obtained by swabbing vaginal tracts and enumerating on HeLa cell
monolayers. IFU data are expressed (mean ± SE) for each Chlamydial strain
from day 3 to35 post infection.*p < 0.001 (L2 vs. D-LC, L2 vs. MoPn), One
way ANOVA.
and reproductive tissues harvested for gross and histological
evaluation.
Extrusions Recovered from the
Cervicovaginal Tract
Vaginal swabs (n = 5) obtained 24 days post infection were
examined by DIC and fluorescent microscopy. Stains for live
cells (Hoescht) and plasma membranes (FM 4-64) were used
to visualize cells. Round Chlamydia-filled plasma membrane
enclosed vesicles were identified as well as vaginal epithelial
cells and cellular debris. Representative images are found
in Figure 2A. These Chlamydia-filled membrane surrounded
structures devoid of nuclei were consistent in size and shape
with previously described extrusions (Hybiske and Stephens,
2007; Lutter et al., 2013; Zuck et al., 2016a). During live
microscopy the Chlamydia were vibrating within the extrusion
changing extrusion shape from circular to amorphous suggesting
the extrusion membranes are highly pliable. The occurrence
of Chlamydia extrusions were observed across all strains (D-
LC, L2, and MoPn). The overall morphological appearance and
size of extrusions were consistent between chlamydial strains.
Sham infected mice were devoid of any extrusions. Additional
studies were conducted to verify the presence of chlamydial EBs
housed inside extrusions via fixed cell imaging. Vaginal swab
and lavage samples collected and fixed at 17 and 20 days post
L2-infection were analyzed by fluorescent microscopy of the
host plasma membrane (FM 4-64FX), chlamydial EBs (anti-L2),
and host nuclei (DAPI). As illustrated in Figure 2B, there is
positive staining (red) for host plasma membrane surrounding
chlamydial EBs (green) within a vesicular structure devoid of host
nuclei. Collectively, our microscopy data provide definitive proof
of chlamydial extrusions shed from the murine cervicovaginal
tract.
Mucosal and Systemic Immune Response
to C. trachomatis and C. muridarum
To compare the mucosal immune response across multiple
strains, vaginal washes were obtained from mice 31 days post
infection with either C. trachomatis serovar D-LC (n = 10), C.
trachomatis serovar L2 (n = 10), or C. muridarum MoPn (n =
10). Vaginal IgA antibody titers against strain-specific EBs were
measured by ELISA (Figure 3). All mice infected with MoPn
produced an anti-Chlamydia mucosal immune response with
IgA titers ranging from 64 to 128, while those infected with
serovar D-LC displayed, on average, lower titers with substantial
variability (p< 0.05 MoPn vs. D-LC). Mice infected with serovar
L2 consistently produced negligible IgA titers (Figure 3A) that
were significantly lower than titers produced by D-LC and
MoPn-infected mice (p < 0.05 L2 vs. D-LC; p < 0.001 L2
vs. MoPn). Sera were collected from sham and infected mice
(n = 5 per group) 35 days post infection. Mice infected with
MoPn exhibited similar titers for both anti-Chlamydia IgG2a and
IgG1 antibodies with little variation between individual mice.
In contrast, mice infected with serovar D-LC and L2 generated
highly variable titers of IgG2a and IgG1 without statistically
significant differences between groups (Figure 3B).
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FIGURE 2 | Presence of extrusions in vivo after infection with
Chlamydia by live and fixed cell microscopy. (A) Live cell microscopy
identified potential extrusions shed from mice infected with each chlamydial
strain tested. Olympus Laser Scanning Confocal microscopy was used to
obtain DIC, nuclear (Hoechst; blue) and plasma membrane (FM 4–64; red)
images on 60X with oil. (B) Fixed cell imaging was used to confirm extrusions
shed from the cervicovaginal tracts infected with C. trachomatis L2. Indirect
immunoflourescent images of fixed extrusions were obtained using a Leica
DMI6000B at 40X magnification. Staining of plasma membrane (FM 4–64 FX;
red), L2 EBs (anti-L2; Green), nuclei (DAPI; blue), and a merged image are
shown.
Histopathological and Morphometric
Assessment of Reproductive Tracts
Following C. trachomatis and
C. muridarum Infection
Reproductive tracts (n = 3 per group) were collected 59
days post infection (sham, D-LC, L2, and MoPn) whereupon
images of gross morphology were captured followed by
formalin fixation for downstream histological evaluation and
morphometric measurements. Gross morphology consistently
FIGURE 3 | Mucosal and systemic antibody responses following
infection with C. trachomatis (serovars D, L2) and C. muridarum
(MoPn). (A). Vaginal washes were collected 31 days post infection (n = 10)
and assayed for the presence of anti-chlamydial secretory IgA. (B) Sera were
collected 35 days post infection (n = 5) and assayed for the presence of
anti-chlamydial IgG2a and IgG1. Antibody titers are expressed for individual
mice as the highest dilution that produced ≥3-fold the absorbance reading of
the control (sham-infected) vaginal wash and sera samples. Bars represent
mean antibody titer per group.**p < 0.001 (L2 vs. MoPn), *p < 0.05 (D vs. L2;
D vs. MoPn), One way ANOVA.
revealed the greatest degree of hydrosalpinx in MoPn-infected
mice (Figure 4F). Sections of uterine tissue were examined
and the scores assigned by an AVCP certified veterinary
pathologist via light microscopy are shown in Table 1. The
overall impression scores of uterine tissues were minimal to
moderate pathology for all infected mice. Moderate pathology
included periglandular mucinous change (Figure 4B), stratum
compactum inflammation, and decreased (p = 0.0001) luminal
epithelial height (Table 1) in D-LC infectedmice relative to sham.
Mice infected with MoPn displayed oviduct dilation (Figure 4D)
and decreased (p = 0.011) luminal epithelial height (Table 1).
The overall impression of tissues and degree of mucinous change
in L2 infected mice were minimal; the luminal epithelial height
did not differ from the sham infected (Table 1).
DISCUSSION
The pathological consequences and reproductive sequelae of
C. trachomatis are well-known; however, the mechanisms
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FIGURE 4 | Gross and Histopathological Assessment of Reproductive Tracts Post Infection. Mice (n = 3 per group) were euthanized 59 days post infection
and entire reproductive tracts were removed for gross assessment followed by formalin fixation for histological evaluation. Images of H&E stained sections of uterine
tissue were captured using an Olympus DP70. (A) Sham infected uterine tissue (20X). (B) C. trachomatis serovar D-LC infected; arrows to areas of mucinous
inflammation (20X). (C) C. trachomatis serovar L2 infected; arrows to areas of luminal inflammation (4X). (D) C. muridarum MoPn infected; arrow indicating oviduct
dilation (4X). (E) Sham infected whole reproductive tract. (F) C. muridarum MoPn infected whole reproductive tract; arrows to areas displaying hydrosalpinx. See
Table 1 for pathological scoring and morphometric measurements of reproductive tracts.
TABLE 1 | Pathological scoring and morphometric measurements of murine reproductive tracts.
Infectious Overall Mucinous Hydrosalpinxa Uterine luminal Stratum Luminal Representative
agent impressiona changea inflammationa compactum epithelial imagesc
inflammationa height (µm)b
Sham 0 0 0 0 0 21.8 (±3.7) Figures 4A,E
D-LC 3.7 (±0.6) 3.3 (±1.2) 0.7 (±0.6) 1.0 (±0) 3.0 (±1.0) 16.8 (±3.2)** Figure 4B
L2 1.7 (±0.6) 0.6 (±0.6) 1.3 (±0.6) 1.3 (±1.5) 2.0 (±0) 24.8 (±7.8) Figure 4C
MoPn 2.7 (±0.6) 2.3 (±1.2) 2.0 (±0) 0.3 (±0.6) 2.0 (±0) 18.7 (±3.3)* Figures 4D,F
aHistological sections of reproductive tracts (n= 3) were examined and scored by an ACVP certified veterinary pathologist via light microscopy with the following numerical designations:
0, normal; 1, minimal change; 2, mild change; 3, moderate change; 4, severe change (mean ± SD).
b Morphometric measurements were collected at six locations (proximal, mid, and distal regions of both uterine horns) determined to be free of tissue bends and uniform. Epithelial
height was measured (mean µm+/–SD) from basement to apical membrane.
c Representative images in Figure 4; bold text indicates the image which corresponds to a given gross or histological feature.
**p = 0.0001, *p = 0.011(sham vs. infected).
related to pathogenesis resulting in Chlamydia-induced damage
are not fully understood. Within this study, three different
chlamydial strains (C. trachomatis D-LC, L2, and C. muridarum
MoPn) were compared for infectivity, mode of host cell exit,
immune response, and sequelae in the cervicovaginal infection
model using C3H/HeJ mice. Mice infected with C. trachomatis
L2 exhibited the highest infectious burden compared to C.
trachomatis D-LC and C. muridarum. This level of increased
infectious burden was not surprising as C. trachomatis L2 has
consistently exhibited a higher level of recoverable Chlamydia
compared to other C. trachomatis serovars (Morrison et al.,
2011). However, there is greater variability when comparing
cervicovaginal infections by other C. trachomatis strains to C.
muridarum. Our data demonstrated an infectious burden for
C. trachomatis serovar D and C. muridarum MoPn that is
consistent with a previous report (Ito and Lyons, 1999) but not
others (Morrison et al., 2011). Morrison et al. (2011) reported
less infectious burden with C. trachomatis serovar D than C.
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muridarum during genital challenge. These differences, however,
may be attributed to their use of different strains ofC. muridarum
(Weiss) and C. trachomatis serovar D (UW-3/CX) compared to
our study. The Weiss strain has been shown by others (Ramsey
et al., 2009) to be less virulent than the Nigg strain, therefore
offering a possible explanation for the lower infectious burden
in our MoPn-infected mice.
The significant finding in this study was the identification
of chlamydial extrusions in vivo. Swabbing the murine vaginal
vault recovered extrusions from infections by all three chlamydial
strains (C. trachomatis D-LC, L2, and C. muridarum MoPn), as
demonstrated by live cell microscopy. However, live cell staining
is limited since antibodies to Chlamydia cannot penetrate live
membranes. Therefore, the shedding of chlamydial EBs enclosed
within extrusions was validated via fixed cell staining of vaginal
lavages collected from L2-infected mice. Consistent with SEM
and confocal microscopy data in previous in vitro reports of
extrusions (Hybiske and Stephens, 2007, 2008; Lutter et al., 2013;
Zuck et al., 2016a,b), the extrusions we collected were filled
with Chlamydia, enclosed in the host plasma membrane, and
devoid of host nuclei. In vivo host cell exit of all three tested
chlamydial strains via the extrusion pathway was hypothesized
based on in vitro data demonstrating that all chlamydial species
tested to date produce extrusions (Hybiske and Stephens,
2007, 2008; Lutter et al., 2013; Zuck et al., 2016a,b), however
documentation was technically challenging in vivo. Extrusions
are produced readily and in high numbers by monolayers
in cell culture (Lutter et al., 2013; Zuck et al., 2016b); on
the other hand, visualization of extrusions produced and shed
from the murine cervicovaginal tract was less abundant. The
disparity in quantity of extrusions shed in vivo vs. in vitro
was expected due to both biological and technical reasons.
Extrusions may be produced in high numbers in vivo, but they
are likely short lived in the harsh environment of the genital
tract (Amjadi et al., 2014; Deruaz and Luster, 2015); pH and
mucinous changes, secretory antibodies, and/or inflammatory
mediators may decrease the quantity of recoverable extrusions.
Likewise, extrusions are physically fragile; mechanical abrasion
during swabbing and/or vaginal lavage protocols jeopardize the
integrity of the extrusions, as well as downstream procedures
for fixation of cells in suspension. Further refinement of
protocols to recover extrusions will be an important next
step in this area of research. Despite biological and technical
challenges of harvesting significant numbers of extrusions in
vivo, the fact that they are recovered from the murine vaginal
mucosa reveals a previously unappreciated mechanism that may
participate in chlamydial pathogenesis in vivo. Recent in vitro
studies demonstrate significant advantages for Chlamydia that
are packaged into extrusions, including enhanced extracellular
survival (Zuck et al., 2016b) and the ability to avoid the
immune system by surviving inside macrophages (Zuck et al.,
2016a). Confirming these advantages in an animal model would
greatly advance our understanding of chlamydial strategies for
survival.
Prevention of C. trachomatis STI is needed since infection
is often unrecognized, re-infection is common and, whether
treated or not, may lead to permanent complications, such
as pelvic inflammatory disease, ectopic pregnancy, and tubal
infertility. Several decades of effort toward vaccine development
has generated extensive knowledge of the immune response
to C. trachomatis in mice, yet replicating it to effectively
convey protection has proved to be difficult. The overriding
challenges stem from the complexity of targeting the bi-phasic
life cycle of this obligate intracellular pathogen and stimulating
immunity at the site of infection, the genital mucosa. There
are several players of the innate and adaptive immune system
that participate in clearance of infection, however it is well
established that γ-IFN secretion by CD4+ Th1 cells is, (i)
the primary requisite to elicit protection against C. muridarum
(Perry et al., 1997; Li et al., 2008; Gondek et al., 2009; Darville
and Hiltke, 2010), and (ii) a major, but not categorical, player
in adaptive immunity against C. trachomatis (Morrison et al.,
2011).
Although clearance will indeed occur in the absence of a
humoral response (Su et al., 1997) the capacity of systemic
and mucosal neutralizing antibodies to reduce bacterial load
is relevant in accelerating protective immunity (Morrison and
Morrison, 2005; Armitage et al., 2014; Olsen et al., 2015).
Bacterial entry and transmission occur at the genital mucosa
which, unlike other mucosal sites, lacks lymphoid architecture.
Migration of chlamydia-specific IL-17 secreting CD4+ T cells
(Th17 cells) to the genital mucosa has recently been recognized
as a critical step for the enhancement of mucosal IgA secretion
(Cunningham et al., 2008; Hirota et al., 2013; Armitage
et al., 2014). We show that mice intravaginally infected with
serovar L2 produced negligible IgA in the vaginal tract while
exhibiting the highest infectious burden, relative to serovar D-
LC and MoPn. This inverse correlation between vaginal IgA
and recoverable L2 IFU is consistent with a recent study in
minipigs infected with serovar L2 wherein significantly lower
vaginal IgA was observed together with a high infectious
burden. Furthermore, their subunit antigen immunization with
a Th1/Th17 adjuvant approach induced significant vaginal IgA
that enhanced clearance of C. trachomatis (Lorenzen et al.,
2015). Our data show mice infected with MoPn consistently
produced high levels of IgA in the vaginal tract while shedding
significantly lower IFU at day 7 through 28 post-infection,
relative to L2-infected mice. Serovar D-LC-infected mice also
shed fewer organisms from the vaginal tract compared to
L2-infected mice, but exhibited substantial variation in the
levels of vaginal IgA. This side-by-side analysis captures the
significant differences in the mucosal response to chlamydial
strains warranting further investigation into the mechanism
whereby serovar L2-infected mice differ in their mucosal IgA
response, which may simply reflect a delayed response as
shown by others (Morrison et al., 2011) or involve a reduction
in homing to and/or function of Th17 cells at the genital
mucosa.
Our comparison of the systemic immune response
consistently revealed similar IgG2a and IgG1 titers between
individual mice infected with MoPn. In contrast, mice infected
with D-LC and L2 exhibited highly variable titers ranging from
non-responders to exceptionally high titers (>11,000 in L2
infected) at 35 days post infection. The mean titer values of
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IgG2a vs. IgG1 in D-LC and L2 infected mice suggest a favoring
of a Th1 (IgG2a) response, but the data were not statistically
significant. The contiguous antibody titers (both mucosal and
systemic) produced by all MoPn-infected mice may be the result
of infection within its natural host as opposed to infection of
mice with human serovars.
According to Table 1 all chlamydial strains resulted in some
degree of uterine pathology indicating minimal to mild overall
changes in L2-infected mice while D-LC and MoPn-infected
mice exhibited mild to moderate pathology. The most significant
observation was a decrease in luminal epithelial height in both D-
LC and MoPn infected mice suggesting atrophy upon excessive
inflammatory damage. In contrast, mice infected with L2
displayed similar luminal epithelial height as the sham infected.
Considering the high infectious burden in L2-infected mice
(relative to D-LC and MoPn) it is interesting that the evaluation
of gross and histological morphology indicated minimal overall
changes in L2-infected mice while D-LC and MoPn exhibited
mild to moderate pathology. L2-infected mice also appeared
normal upon assessment for mucinous changes. In contrast,
serovar D-LC produced the largest mucinous change, but the
least degree of hydrosalpinx. This is overall consistent with other
studies comparing C. trachomatis and C. muridarum although
the reasons for the differences in local inflammation are not
fully understood; the complete vs. partial set of chlamydial
cytotoxin genes offer a possible explanation (Belland et al.,
2001). MoPn has been shown to contain genes that encode
proteins with homology to large cytotoxins and exerts cytopathic
effects in HeLa cells, however serovar L2 lacks a substantial
portion of these cytotoxin genes and does not produce cytopathic
effects in vitro. Serovar D displays a lesser degree of genetic
deletion and retains the capacity to drive intermediate cytopathic
effects in vitro (Belland et al., 2001). This genetic variation in
chlamydial cytotoxins may be a factor in the histopathological
differences observed across strains tested herein. Additionally,
histopathological differences may arise due to high IgA titers in
the vaginal tracts of D-LC and MoPn-infected mice that drive
inflammatory damage while L2-infected mice, which produced
negligible IgA, experienced less inflammatory damage. This
could be another example of the “double-edged sword” concept
of cell mediated immune responses that are necessary to clear
infection, but cause excessive tissue damage in the process. It
has been reported that Th17 cells, which enhance mucosal IgA,
stimulate excessive neutrophil-mediated inflammatory damage
(Darville and Hiltke, 2010). Therefore, it would be interesting
to repeat our study to investigate the cytokine and chemokine
profile produced by CD4+ Th1 and Th17 cell populations. This
would advance our understanding of strain-specific mechanisms
that result in different reproductive sequelae as well as contribute
to vaccine efforts toward promoting a Th1 immune response
with minimal collateral tissue damage at the reproductive
tract.
FUTURE DIRECTIONS
Our data are the first to identify chlamydial extrusions shed from
a murine cervicovaginal infection model. Though, the biological
role of chlamydial extrusions during infection is not known, the
overall morphology of extrusions appears conserved between in
vitro and in vivo infection. An important next step includes the
refinement of in vivo techniques to collect extrusions in quantities
sufficient for functional assays between chlamydial strains and
serovars. Moreover, establishing animal infection models that
retain fluorescently labeled Chlamydia strains (e.g., L2-GFP)
will provide means of quantification and a more comprehensive
analysis of the extrusions produced during in vivo infections.
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